Vitamin D is a seco-steroid hormone with multiple functions in the nervous system. We discuss clinical and experimental evidence of the role of vitamin D in normal and pathological brain functions, and analyze the relative importance of vitamin D-modulated brain mechanisms at different stages of life. We also outline perspectives for the use of vitamin D in clinical nutrition to prevent or treat various brain disorders. Recent findings Numerous brain dysfunctions are linked to vitamin D deficits and/or dysfunctions of its receptors. In both animals and humans, vitamin D serves as an important endogenous and/ or exogenous regulator of neuroprotection, antiepileptic and anticalcification effects, neuro-immunomodulation, interplay with neurotransmitters and hormones, modulation of behaviors, brain ageing, and some other, less-explored, brain processes. Summary Vitamin D emerges as an important neurosteroid hormone in the brain, with a strong potential for age-specific applications in clinical nutrition. ]. 1,25-D regulates the expression of numerous target genes through the nuclear vitamin D receptor (VDR), belonging to a common family of steroid receptors that also includes steroid, glucocorticoid and retinoic acid receptors. The mechanism of the genome effects of vitamin D is similar to that of all other steroid hormones. Upon binding 1,25-D, the VDR undergoes a conformational change and binds to vitamin D response DNA elements in the promoter regions of target genes, controlling their transcription. The rapid response to vitamin D uses a nongenomic signal transduction pathway and is believed to occur via putative membrane receptors for 1,25-D, whose functions and properties are not yet well understood [2,5,6 ].
].
VDR autoradiography is an important tool to study vitamin D brain targets and its in-vivo histopharmacology with high resolution and sensitivity [7, 8] . Since pioneering works [9,10] reported high-affinity vitamin D binding to the brain (Figs 1 and 2), the biological importance of this hormone in the central nervous system (CNS) is now recognized and these results are confirmed by immunological methods (e.g. [11, 12] ). Mounting evidence for the presence of vitamin D, its receptors (VDR), and enzymes of bioactivation/metabolism in brain neurons, glial cells, brain macrophages, spinal cord and the peripheral nervous system confirms its role as an autocrine or paracrine neuroactive steroid, thus fulfilling the criteria for a neurosteroid [9,12-14,15 ,16,17] .
Several recent reviews discussed the role of vitamin D in brain functioning and development [5,6 ,14,18,19 ]. This reflects a marked paradigmal shift in modern endocrinology, evolving from initial refusal to gradual acceptance of brain actions of vitamin D [9,10,14,20 ] (Table 1) . Clearly, it took both time and caution before vitamin D ceased being 'neglected' [17] , and was finally accepted as a neuroactive/neurosteroid hormone [6 , 19 ]. The aim of the present paper is to critically discuss recent developments in this field and outline future perspectives of research, focusing on vitamin D application for clinical nutrition.
Vitamin D and the nervous system
We have recently summarized [6 ] brain functions of vitamin D, outlining potentially important targets for the creation of novel effective neurotropic drugs for human disorders (see also Table 1 for details). In addition to altering brain morphology, neurochemistry and physiology, there are numerous data that link vitamin D and VDR to the regulation of behavior. VDRs are found in key brain areas including the cortex, cerebellum and limbic system, all known to regulate behavior [9, 12] (Figs 1 and 2 ). In humans, vitamin D deficiency has long been known to be accompanied by irritability, anxiety, depression, psychoses and defects in mental development [6 ,53 ,54,61,65] . The psychotropic mood-elevating effects of vitamin D have also been well documented in the literature [18,54,57] (but see [66] [77 ] have recently shown that developmental vitamin D deficiency altered behaviors of adult rats, leading to increased baseline and psychostimulantevoked locomotion. Combined prenatal and chronic postnatal vitamin D deficiency has been reported to impair prepulse inhibition and produce hyperlocomotion in rats [23 ,78,79] . Transient prenatal vitamin D deficiency has been shown to result in alterations in memory and learning in rats [80 ,81 ] . Collectively, this suggests that vitamin D could be an important endogenous and exogenous factor controlling brain functions and behaviors, and its deficiency leads to marked behavioral and physiological anomalies (see also [6 ,82 ] for reviews of some earlier data).
Mice with genetically impaired VDR (knockout mice) represent another interesting model of vitamin D dysfunctions, focusing on the biological functions of vitamin D and VDR in the brain [55,82 ,83,84 ]. Marked behavioral differences were found in these mice, including high anxiety and aberrant grooming [55, 82 ] . VDR knockout mice also displayed specific motor impairments, indicating serious motor (and, possibly, vestibular) defects [82 ,85 ] . Interestingly, VDR knockout male and female mice built less-complex and incomplete nests, and also showed a dramatic impairment of the VDR knockout maternal behavior [84 ] , implying possible involvement of prolactin and oxytocin-related mechanisms (see, e.g., [86] for prolactin deficits in these mice).
These mice were predictably insensitive to known therapeutic effects of 1,25-D in experimental allergic encephalomyelitis, an animal model of MS [45] , confirming the importance of vitamin D and VDR in neuro-immunomodulation. Recently, some other brain anomalies, including higher sensitivity to seizures and thalamic calcification, have been reported in these mice 
New directions of research
Mounting clinical and experimental data evidence a particularly important role of vitamin D in the ageing brain, as due to both low dietary intake and sun exposure, the elderly have insufficient vitamin D levels [87] , accompanied by well-documented behavioral and cognitive decline. Using animal models, Moore et al. [46 ] reported that vitamin D protects against age-related inflammatory changes in the rat hippocampus. In line with this, Brewer et al. [88 ] noted that chronic vitamin D treatment in rats effectively reduces hippocampal neurophysiological biomarkers of ageing. Given the important role of the hippocampus in cognitive processes during ageing, such effects of vitamin D on the hippocampus may explain why vitamin D status influences age-related cognitive dysfunctions. Interestingly, Razzaque et al. [89, 90] have recently shown that fibroblast growth factor 23 knockout mice are characterized by premature ageing accompanied by pronounced hypervitaminosis D and aberrant mineral homeostasis.
Similar results have been reported for klotho, a new hormonal regulator of ageing, strongly linked to the vitamin D system [90] [91] [92] [93] . The klotho gene is expressed in kidney and choroid plexus in the brain [94, 95] , and its ablation in mice leads to premature ageing [92, 93] . While vitamin D administration upregulates this gene, mice lacking klotho display elevated serum calcium, phosphorus and 1,25-D [91] [92] [93] [94] . Reduced vitamin D levels (by dietary restriction or genetic ablation of 1a-hydroxylase) alleviate many of these phenotypes, indicating that klotho regulates vitamin D levels and that both hormones ,100]. In line with this, Stumpf et al. [101] reported serotoninelevating effects of a vitamin D-rich diet in rat hypothalamus. Our recent studies using chemically induced seizures [36, 102] suggested a link between vitamin D/VDR and central g-aminobutyric acid. Clearly, further studies are needed to clarify the exact role of vitamin D (and its deficiency) on key brain mediators, as well as its interplay with other steroid-like [62] and nonsteroid hormones [6 ] in both central and peripheral tissues.
Notably, using different types of vitamin D depletion in rats, Burne et al. [78] have demonstrated that behavioral effects (impaired prepulse inhibition) of vitamin deficiency were only seen in combined prenatal plus chronic postnatal, but not in the early life groups. These findings outline a new direction of research in this field, as they not only demonstrate the importance of vitamin D status for brain functions throughout lifetime, but also contribute to our understanding of potential environmental postnatal (vs. purely genetic or prenatal) vitamin Drelated influences on brain disorders.
In addition to future experimental studies using mutant and transgenic animals with aberrant vitamin D system, further clinical studies are needed to examine the link between genetic anomalies in the vitamin D/VDR system and various psychiatric disorders. For example, it is necessary to examine whether vitamin D deficiency may lead to MS and other disorders only in susceptible individuals [58, 73] . Likewise, it is necessary to assess whether vitamin D supplementation would differentially affect genetically susceptible individuals [71] . Finally, more clinical and preclinical research is needed to study the role of other genes beyond VDR, as well as the role of gene-gene and gene-environment interactions in vitamin D-related mechanisms of ageing [88 ,89,90] , MS and other CNS disorders [58, 73, 74 ]. Fig. 3) .
Conclusion
Notably, the major problem with vitamin D therapy at any stage is its widely recognized toxic (hypercalcemic) and cardiovascular effects. This fact divides scientists into those who express reservation and caution (e.g. [104] Fig. 3 ) may help resolve these discrepancies, maximizing patients' benefits from vitamin D supplementation. From this point of view, high dietary doses of vitamin D merit further testing in various animal models [39, 78] . Finally, a rational strategy 16 Aging: biology and nutrition ] but see [60 , [61] [62] [63] [64] is to facilitate the search for novel selective drugs based on vitamin D low-calcemic analogs (e.g. [44 ] ) that retain other beneficial neuroactive properties of this hormone.
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